ABSTRACT
Purpose
Enhancing oral bioavailability of vinpocetine by forming its amorphous citrate salt through a solvent-free mechanochemical process, in presence of micronised crospovidone and citric acid.
Methods
The impact of formulation and process variables (amount of polymer and citric acid, and milling time) on vinpocetine solubilization kinetics from the coground was studied through an experimental design. The best performing samples were characterized by employing a multidisciplinary approach, involving Differential scanning calorimetry, X-ray diffraction, Raman imaging/spectroscopy, X-ray photoelectron spectroscopy, solid-state NMR spectroscopy, porosimetry and in vivo studies on rats to ascertain the salt formation, their solid-state characteristics and oral bioavailability in comparison to vinpocetine citrate salt (Oxopocetine®).
Results
The analyses attested that the mechanochemical process is a viable way to produce in absence of solvents vinpocetine citrate salt in an amorphous state.
Conclusion
From the in vivo studies on rats the obtained salt was four times more bioavailable than its physical mixture and bioequivalent to the commercial salt produced by conventional synthetic process implying the use of solvent.
Similar content being viewed by others
REFERENCES
Bencsath P, Debrczeni L, Takács L. Effect of ethyl apovincaminate on cerebral circulation of dogs under normal conditions and in arterial hypoxia. Arzneim-Forsch/Drug Res. 1976;26:1920–3.
Luo Y, Chen D, Ren L, Zhao X, Qin J. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release. 2006;114:53–9.
Csanda E, Harcos P, Bacsy Z, Berghammer R, Kenez J. Ten years of experience with Cavinton. Drug Dev Res. 1988;14:185–7.
Grandt R, Beitinger R, Schateltenbrand R, Braun W. Vinpocetine pharmacokinetics in elderly subjects. Arzneim-Forsch/Drug Res. 1989;39:1599–602.
Szakacs T, Veres Z, Vereczkey L. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine. Pol J Pharmacol. 2001;53:623–8.
Kata M, Lukacs M. Enhancement of solubility of vinpocetine base with γ-cyclodextrin. Pharmazie. 1986;41:151–2.
Ribeiro L, Ferreira D, Veiga F. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexationwith β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci. 2003;20:253–66.
Ribeiro L, Falcao AC, Patricio JAB, Ferreira DC, Veiga FJB. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavalaibility of vinpocetine. J Pharm Sci. 2007;96:2018–28.
Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-β-cyclodextrin. Arch Pharm Res. 2007;30:991–1001.
Nie S, Pan W, Li X, Wu X. The effect of citric acid added to hydroxypropyl methylcellulose (HPMC) matrix tablets on the release profile of vinpocetine. Drug Dev Ind Pharm. 2004;30:627–35.
Miskolczi P, Vereczkey L, Szalay L, Göndöcs C. Effect of age on pharmacokinetics of Vinpocetine (Cavinton) and Apovincamininc acid. Eur J Clin Pharmacol. 1987;33:185–9.
Chen Y, Li G, Wu X, Chen Z, Hang J, Qin B, et al. Self-microemulsifying drug delivery system (SMEDDS) of vinpocetine: formulation development and in vivo assessment. Biol Pharm Bull. 2008;31:118–25.
Iosio T, Voinovich D, Grassi M, Pinto JF, Perissutti B, Zacchigna M, et al. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur J Pharm Biopharm. 2008;69:686–97.
Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 2009;35:603–11.
Hasa D, Voinovich D, Perissutti B, Bonifacio A, Grassi M, Franceschinis E, et al. Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone. J Pharm Sci. 2011;100:915–32.
Calvo F, Manresa MT. Citric acid salt of (+) vinpocetine. U.S. patent 4749707. Spain: Covex S.A.; 1988.
Shakhtshneider TP, Boldyrev VV. Mechanochemical synthesis and mechanical activation of drugs. In: Boldyreva E, Boldyrev V, editors. Reactivity of molecular solids. Chichester: Wiley; 1999. p. 271–311.
Voinovich D, Perissutti B, Grassi M, Passerini N, Bigotto A. Solid state mechanochemical activation of Silybum Marianum dry extract with betacyclodextrins: characterization and bioavailability of the coground systems. J Pharm Sci. 2009;98:4119–29.
Mathieu D, Nony J, Phan-Tan-Luu R. NEMRODW (New Efficient Technology for Research using Optimal Design) software. Marseille: LPRAI; 1999.
R Development Core Team. R: a language and environment for statistical computing. Wien: R Foundation for Statistical Computing; 2009. ISBN 3-900051-07–0. Available from: http://www.R-project.org.
Beleites C, Sergo V. http://hyperspec.r-forge.r-project.org for R (see reference 20); 2009.
Carli F, Motta A. Particle size and surface area distribution of pharmaceutical powders by microcomputerized mercury porosimetry. J Pharm Sci. 1984;73:197–203.
Cadelli G, Zarattini P, Stebel M. Further refinements of tail artery cannulation in conscious rats, Centro Coordinamento e Sviluppo progetti e Apparecchiature (CSPA). Settore stabulario e sperimentazione animale. Università di Trieste., FELASA-ICLAS Joint Meeting –Villa Erba, Cernobbio; 2007.
Vlase L, Bodiu B, Leucuta SE. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter. Arzneim-Forsch/Drug Res. 2005;55:664–8.
Mura P, Faucci MT, Manderioli A, Bramanti G. Multicomponent systems of econazole with hydroxyacids and cyclodextrins. J Incl Phenom. 2001;39:131–8.
Lu Q, Zografi G. Properties of the citric acid at the glass transition. J Pharm Sci. 1997;86:1374–8.
Voinovich D, Perissutti B, Magarotto L, Ceschia D, Guiotto P, Bilia AR. Solid state mechanochemical simultaneous activation of the constituents of the silybum marianum phytocomplex with crosslinked polymers. J Pharm Sci. 2009;98:215–28.
Colombo I, Grassi G, Grassi M. Drug mechanochemical activation. J Pharm Sci. 2009;98:3961–86.
Rawlinson CF, Williams CA, Timmins P, Grimsey I. Polymer-mediated disruption of drug crystallinity. Int J Pharm. 2007;336:42–8.
Trapani G, Latrofa A, Franco M, Pantaleo MR, Sanna E, Massa F, et al. Complexation of zolpidem with 2-hydroxypropyl-β-, methyl-β-, and 2-hydroxypropyl-γ-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat. J Pharm Sci. 2000;89:1443–51.
Grassi M, Coceani N, Magarotto L, Ceschia D. Effect of milling time on release kinetics from co-grounded drug-polymer systems. Proceedings of the AAPS Annual Meeting and Exposition, October, Salt Lake City, USA; 2003.
Karagedov GR, Konovalova EA, Boldyrev VV, Lyachov NZ. Influence of reagent biography and reaction conditions on kinetics of lithium ferrite synthesis. Solid State Ionics. 1990;42:147–51.
Alonzo DE, Zhang GGZ, Zhou D, Gao Y, Taylor LS. Understanding the behaviour of amorphous pharmaceutical systems during dissolution. Pharm Res. 2010;27:608–18.
Groen H, Roberts KJ. Nucleation growth and pseudo-polymorphic behavior of citric acid as monitored in situ by Attenuated Total Reflection Fourier Transform Infrared Spectroscopy. J Phys Chem B. 2001;105:10723–30.
Poerwono H, Higashiyama K, Kubo H, Poernomo AT, Suharjono, Sudiana IK, et al. Citric acid. In: Brittain HG, editor. Analytical profiles of drug substances and excipients, vol. 28. Boston: Academic; 2001. p. 1–76.
Stevens JS, Byard SJ, Schroeder SLM. Salt or co-crystal? Determination of protonation state by X-Ray Photoelectron Spectroscopy (XPS). J Pharm Sci. 2010;99:4453–7.
Braga D, Grepioni F, Polito M, Chierotti MR, Ellena S, Gobetto R. A solid-gas route to polymorph conversion in crystalline [Fe-II(eta5-C5H4COOH)2]. A diffraction and solid-state NMR study. Organometallics. 2006;25:4627–33.
Chierotti MR, Gobetto R. Solid-state NMR studies of weak interactions in supramolecular systems. Chem Commun. 2008;14:1621–34.
ACKNOWLEDGMENTS
The authors thank Linnea (Locarno, CH) and Covex (Madrid, ES) for kindly donating the active ingredients used in this study, D. Lenaz for his precious advices and S. Bhardwaj, from TASC-IOM-CNR AREA Science Park, Trieste, Italy, for assistance during XPS analyses.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hasa, D., Voinovich, D., Perissutti, B. et al. Enhanced Oral Bioavailability of Vinpocetine Through Mechanochemical Salt Formation: Physico-Chemical Characterization and In Vivo Studies. Pharm Res 28, 1870–1883 (2011). https://doi.org/10.1007/s11095-011-0415-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-011-0415-8